Effect of milrinone on cardiac functions in patients undergoing coronary artery bypass graft: A meta-analysis of randomized clinical trials

Drug Design, Development and Therapy

Volumn 10, Issue , 2015, Pages 53-58

  You, Zhigang ^a   Huang, Lin ^a   Cheng, Xiaoshu ^a   Wu, Qinghua ^a   Jiang, Xinghua ^a   Wu, Yanqing ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Cardiac function; Clinical trial; Inotropic support; Intra aortic balloon pump; Meta analysis

Indexed keywords

MILRINONE; NESIRITIDE; PLACEBO; CARDIOTONIC AGENT;

ARTICLE; ARTIFICIAL VENTILATION; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HEART ATRIUM ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; INFORMATION RETRIEVAL; INTENSIVE CARE UNIT; INTRAAORTIC BALLOON PUMP; META ANALYSIS; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; SAMPLE SIZE; SURVIVAL; LENGTH OF STAY; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MILRINONE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84952789325     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S77464     Document Type: Article

References (19)

1. Möllhoff T, Schmidt C, Deng MC. Myocardial ischaemia in patients with impaired left ventricular function undergoing coronary artery bypass grafting - milrinone versus nifedipin. Eur J Anaesthesiol. 2002;19(11):796-802.
2. Heringlake M, Wernerus M, Grunefeld J, et al. The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting. Crit Care. 2007;11(2):R51.
3. Abu-Omar Y, Taggart DP. The present status of off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg. 2009;36(2):312-321.
4. Kikura M, Levy JH, Michelsen LG, et al. The effect of milrinone on hemodynamics and left ven-tricular function after emergence from cardiopulmonary bypass. Anesth Analg. 1997;85:16-22.
5. Monrad ES, Baim DS, Smith HS, Lanoue AS. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation. 1986;73:III 168-174.
6. Kwak YL, Oh YJ, Shinn HK, Yoo KJ, Kim SH, Hong YW. Haemodynamic effects of a milrinone infusion without a bolus in patients undergoing off-pump coronary artery bypass graft surgery. Anaesthesia. 2004;59:324-331.
7. Doolan LA, Jones EF, Kalman J, et al. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:37-41.
8. Lobato EB, Florete O Jr, Bingham HL. A single dose of milrinone facilitates separation from cardiopulmonary bypass in patients with pre-existing left ventricular dysfunction. Br J Anaesth. 1998;81:782-784.
9. Jebeli M, Ghazinoor M, Mandegar MH, et al. Effect of milrinone on short-term outcome of patients with myocardial dysfunction undergoing coronary artery bypass graft: a randomized controlled trial. Cardiol J. 2010;17(1):73-78.
10. Hadadzadeh M, Hosseini SH, Mostafavi Pour Manshadi SM, Naderi N, Emami Meybodi M. Effect of milrinone on short term outcome of patients with myocardial dysfunction undergoing off-pump coronary artery bypass graft: a randomized clinical trial. Acta Med Iran. 2013;10:681-686.
11. Bailey JM, Levy JH, Kikura M, Szlam F, Hug CC Jr. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology. 1994;81(3):616-622.
12. Gorodeski EZ, Chu EC, Reese JR, Shishehbor MH, Hsich E, Starling RC. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Circ Heart Fail. 2009;2:320-324.
13. Oztekin I, Yazici S, Oztekin DS, Goksel O, Issever H, Canik S. Effects of low-dose milrinone on weaning from cardiopulmonary bypass and after in patients with mitral stenosis and pulmonary hypertension. Yakugaku Zasshi. 2007;127(2):375-383.
14. Yamaguchi A, Tanaka M, Naito K, Kimura C, Kobinata T, Okamura H. The efficacy of intravenous milrinone in left ventricular restoration. Ann Thorac Cardiovasc Surg. 2009;15(4):233-238.
15. Levy JH, Bailey JM, Deeb GM. Intravenous milrinone in cardiac surgery. Ann Thorac Surg. 2002;73(1):325-330.
16. Konstam MA, Cody RJ. Short-term use of intravenous milrinone for heart failure. Am J Cardiol. 1995;75(12):822-826.
17. Song JW, Jo YY, Jun NH, Kim HK, Kwak YL. The effect of milrinone on the intraoperative hemodynamics during off-pump coronary bypass surgery in patients with an elevated echocardiographic index of the ventricular filling pressure. Korean J Anesthesiol. 2011;60(3):185-191.
18. Brackbill ML, Stam MD, Schuller-Williams RV, Dhavle AA. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients. Ann Pharmacother. 2007;41(3):427-432.
19. Zangrillo A, Biondi-Zoccai G, Ponschab M, et al. Milrinone and mortality in adult cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2012;26(1):70-77.